A randomized phase III trial of cisplatin with or without S-1 in patients with FIGO IVB, recurrent, or persistent cervical cancer: An Asian study.

被引：3
|
作者：
Lim, Soyi
Ochiai, Kazunori
Aoki, Yoichi
Aoki, Daisuke
Kamiura, Shoji
Lin, Hao
Fujiwara, Yasuhiro
Cha, Soon Do
Kim, Jae Hoon
Kim, Byoung
Hirashima, Yasuyuki
Fujiwara, Keiichi
Kim, Young Tak
Kim, Seok-Mo
Chung, Hyun Hoon
Chang, Ting-Chang
Kamura, Toshiharu
Takizawa, Ken
Takeuchi, Masahiro
Kang, Soon-Beom
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.5527
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5527
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer
    Aoki, Yoichi
    Ochiai, Kazunori
    Lim, Soyi
    Aoki, Daisuke
    Kamiura, Shoji
    Lin, Hao
    Katsumata, Noriyuki
    Cha, Soon-Da
    Kim, Jae-Hoon
    Kim, Byoung-Gie
    Hirashima, Yasuyuki
    Fujiwara, Keiichi
    Kim, Young-Tak
    Kim, Seok Mo
    Chung, Hyun Hoon
    Chang, Ting-Chang
    Kamura, Toshiharu
    Takizawa, Ken
    Takeuchi, Masahiro
    Kang, Soon-Beom
    [J]. BRITISH JOURNAL OF CANCER, 2018, 119 (05) : 530 - 537
  • [2] Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer
    Yoichi Aoki
    Kazunori Ochiai
    Soyi Lim
    Daisuke Aoki
    Shoji Kamiura
    Hao Lin
    Noriyuki Katsumata
    Soon-Do Cha
    Jae-Hoon Kim
    Byoung-Gie Kim
    Yasuyuki Hirashima
    Keiichi Fujiwara
    Young-Tak Kim
    Seok Mo Kim
    Hyun Hoon Chung
    Ting-Chang Chang
    Toshiharu Kamura
    Ken Takizawa
    Masahiro Takeuchi
    Soon-Beom Kang
    [J]. British Journal of Cancer, 2018, 119 : 530 - 537
  • [3] A randomized phase III trial of four cisplatin (CIS) containing doublet combinations in stage IVB, recurrent or persistent cervical carcinoma: a gynecologic oncology group (GOG) study.
    Monk, B. J.
    Sill, M.
    McMeekin, D. S.
    Cohn, D. E.
    Ramondetta, L.
    Boardman, C. H.
    Benda, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Phase II study of S-1 in patients with advanced or recurrent cervical cancer
    Hirai, Y.
    Katsumata, N.
    Kamiura, S.
    Sugiyama, T.
    Kokawa, K.
    Hatae, M.
    Nishimura, R.
    Ochiai, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS) with S-1 plus cisplatin (SP) in gastric cancer patients with stage III (POST trial).
    Lee, Choong-kun
    Jung, Minkyu
    Kang, Seok Yun
    Kim, Bong-Seog
    Kim, Ki Hyang
    Lee, Kyung Hee
    Lee, Moon Hee
    Shin, Dong Bok
    Zang, Dae Young
    Ahn, Ji Yeong
    Kim, Hyoung-il
    Hyung, Woo Jin
    Noh, Sung Hoon
    Kim, Hyo Song
    Chung, Hyun Cheol
    Rha, Sun Young
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study
    Monk, Bradley J.
    Sill, Michael W.
    McMeekin, D. Scott
    Cohn, David E.
    Ramondetta, Lois M.
    Boardman, Cecelia H.
    Benda, Jo
    Cella, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) : 4649 - 4655
  • [7] Randomized phase III study of S-1 alone versus S-1+cisplatin in the treatment for advanced gastric cancer (The SPIRITS trial) SPIRITS: S-1 plus cisplatin vs S-1 in RCT in the treatment for stomach cancer
    Narahara, H.
    Koizumi, W.
    Hara, T.
    Takagane, A.
    Akiya, T.
    Takagi, M.
    Miyashita, K.
    Nishizaki, T.
    Kobayashi, O.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Phase II trial of topotecan, cisplatin, and bevacizurnab for recurrent or persistent cervical cancer
    Zighelboim, I.
    Wright, J. D.
    Powell, M. A.
    Case, A. S.
    Eisenhauer, E. L.
    Cohn, D. E.
    Valea, F. A.
    Secord, A. A.
    Lippmann, L. T.
    Rader, J. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Phase II trial of topotecan, cisplatin, and bevacizumab for recurrent or persistent cervical cancer
    Zighelboim, Israel
    Wright, Jason D.
    Gao, Feng
    Case, Ashley Stephens
    Massad, L. Stewart
    Mutch, David Gardner
    Powell, Matthew A.
    Thaker, Premal H.
    Eisenhauer, Eric Lawernce
    Cohn, David E.
    Valea, Fidel A.
    Secord, Angeles Alvarez
    Lippmann, Lynne T.
    Rader, Janet Sue
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] Meta-analysis of randomized phase II and phase III trials of gemcitabine with/without S-1 in Asian patients with advanced pancreatic cancer
    Ku, Geoffrey Yuyat
    Haaland, Benjamin
    Ioka, Tatsuya
    Isayama, Hiroyuki
    Nakai, Yousuke
    Cheng, Ann-Lii
    Okusaka, Takuji
    Lopes, Gilberto de Lima
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345